Exosome therapy market projected to grow through 2030

The exosome therapy market is expanding as a significant sector within biotechnology and regenerative medicine. Driven by research into extracellular vesicles, these small vesicles can transport biological molecules between cells, making them potential vehicles for targeted drug delivery, cancer treatment, and addressing neurological or cardiovascular diseases.

Advances in the isolation, engineering, and manufacturing of exosomes are facilitating the development of new therapeutic platforms. According to MarketsandMarkets, the global exosome research market is projected to grow from USD 214.4 million in 2025 to USD 480.6 million by 2030, representing a compound annual growth rate (CAGR) of 17.5%.

Key applications under investigation include immunotherapy, gene and RNA delivery, tissue repair, and anti-inflammatory therapies. While research is progressing rapidly, many exosome-based approaches remain in the investigative stages due to ongoing technical and regulatory considerations.